Pengaruh rasio keuangan terhadap pertumbuhan laba dengan ukuran perusahaan sebagai variabel moderasi pada perusahaan sub sektor farmasi yang terdaftar di Bursa Efek Indonesia

Abstract

This research was conducted to determine what can affect profit growth in pharmaceutical sub-sector companies for 2019-2021. The independent variables used in this research are ROA, DAR, CR, and TATO to determine why companies are experiencing profit growth. This study uses firm size as a moderating variable to determine whether it can strengthen the relationship between the independent variables and earnings growth. Using a purposive sampling technique, the sample in this study used 10 pharmaceutical sub-sector companies listed on the Indonesia Stock Exchange for the 2019-2021 period. The data analysis technique used in this study is panel data regression and moderation regression. The results of this study state that ROA and DAR have a positive effect on profit growth. In contrast, the CR and TATO variables do not affect profit growth because profit growth occurs when the assets owned by a company can be put to good use to generate profits. Then the size of the company cannot be a moderating variable in this study because the size of the company does not guarantee profit growth in a company, but rather how the company's ability to manage its assets to generate profits. The results of this study can be used as a comparison or reference for research with similar topics. This study has implications that the level of sales and debt management of a company has an essential role in achieving profit growth.